GCM
DGX icon

Grisanti Capital Management’s Quest Diagnostics DGX Stock Holding History

Grisanti Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-32,667
Closed -$3.52M – 63
2018
Q3 		$3.52M Sell
32,667
-3,958
-11% -$434K 1.73% 22
2018
Q2 		$4.03M Buy
+36,625
New +$3.82M 1.75% 24

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Grisanti Capital Management's DGX Position: Q4 2018 in Review

Grisanti Capital Management sold out of Quest Diagnostics (DGX) in Q4 2018, closing a stake of 32,667 shares — an estimated $3.52M sold.

Grisanti Capital Management first reported a position in DGX in Q2 2018 and held it in 2 quarters. The position peaked at $4.03M in Q2 2018. 624 funds tracked by Wall St. Rank hold DGX as of Q4 2018.

  • Grisanti Capital Management reported no remaining Quest Diagnostics position as of Q4 2018 after selling out during the quarter.
  • Grisanti Capital Management sold 32,667 Quest Diagnostics shares in Q4 2018, an estimated $3.52M.
  • Grisanti Capital Management first reported a position in Quest Diagnostics in Q2 2018 and held it in 2 quarters.
  • Grisanti Capital Management's Quest Diagnostics position peaked at $4.03M in Q2 2018.
  • 624 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.

Based on Grisanti Capital Management's 13F filing for Q4 2018, filed 7 Feb 2019.